References
- Davies MJ, Thomas AC, Knapman PA, Hangarter JR. Intramyocardial platelet aggregation in patients with acute myocardial infarction suffering sudden ischemic cardiac death. Circulation 1986; 73: 418–427.
- Eccleston D, Topol EJ. Inhibitors of platelet IIb/IIIa as augmenters of thrombolysis. Coron Artery Dis 1995; 6: 947–955.
- Parise P. Hauert J, Iorio A, Callegari P. Agnelli G. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in acute myocardial infarction. J Lab Clin Med 1995; 125: 212–221.
- Terres W, Unmus S, Mathey DG, Bleifeld W. Effects of streptokinase, urokinase, and tissue plasminogen acti-vator on platelet aggregability and stability of platelet aggregates. Cardiovasc Res 1990; 67: 1175–1181.
- O'Brein JR, Etherington MD, Shuttleworth RD, Calwell WH. Platelet function in acute myocardial infarction patients compared to controls. Thromb Haemost 1980; 44: 96–99.
- Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction. Am Heart J 1998; 136: 398–405.
- Bertolino G, Noris P. Previtali M, et al. Platelet function after in vivo and in vitro treatment with thrombolytic agents. Am J Cardiol 1992; 69: 457–461.
- Gurbel PA, Serebruany VL, Shustov AR, et al. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. The GUSTO III Platelet Study. J Am Coll Cardiol 1998; 31: 1466–1473.
- Serebruany VL, Gurbel PA, Shustov AR, et al. Depressed platelet status in a patient with hemorrhagic stroke following thrombolysis for acute myocardial infarction. Stroke 1998; 29: 235–238.
- The GUSTO III Investigators. A comparison of reteplase and alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118–1123.
- Ruggeri ZM. New insights into the mechanisms of platelet adhesion and aggregation. Sem Hemat 1994; 31: 229–239.
- Ault KA. Flow cytometric measurement of platelet function and reticulated platelets. Ann New York Acad Sci 1993; 677: 293–308.
- Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein Hb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IM-PACT-AMI Investigators. Circulation 1997; 95: 846–854
- Kleiman NS, Ohman EM, Califf RM, et al. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Mycardial Infarction (TAMI) 8 Pilot Study. J Am Coll Cardiol 1993; 22: 381–389.
- Smalling RW, Bode C, Kalbfleisch J, et al. More rapid, complete and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute mycardial infarction. RAPID investi-gators. Circulation 1995; 91: 2725–2732.
- Gurbel PA, Serebruany VL, Shustov AR, et al. Increased baseline platelet P-selectin, and PECAM-1 as predictors of unsuccessful thrombolysis in patients with acute myocardial infarction. Coron Artery Dis 1998; 9: 451–456.